Similar articles for PMID: 31065505

Year	Number of Results
2004	2
2005	1
2006	1
2007	1
2008	1
2010	5
2011	6
2012	4
2013	2
2014	3
2015	6
2016	6
2017	6
2018	6
2019	15
2020	16
2021	13
2022	10
2023	7
2024	0

1

Anthraquinone Derivative Reduces Tau Oligomer Progression by Inhibiting Cysteine-Cysteine Interaction.

Areche C, Zapata F, González M, Díaz E, Montecinos R, Hernández M, Melo F, Cornejo A. Areche C, et al. ChemistryOpen. 2019 Feb 8;8(5):554-559. doi: 10.1002/open.201800222. eCollection 2019 May. ChemistryOpen. 2019. PMID: 31065505 Free PMC article.

2

Targeting the ensemble of heterogeneous tau oligomers in cells: A novel small molecule screening platform for tauopathies.

Lo CH, Lim CK, Ding Z, Wickramasinghe SP, Braun AR, Ashe KH, Rhoades E, Thomas DD, Sachs JN. Lo CH, et al. Alzheimers Dement. 2019 Nov;15(11):1489-1502. doi: 10.1016/j.jalz.2019.06.4954. Epub 2019 Oct 22. Alzheimers Dement. 2019. PMID: 31653529 Free PMC article.

3

C1 Inhibits Liquid-Liquid Phase Separation and Oligomerization of Tau and Protects Neuroblastoma Cells against Toxic Tau Oligomers.

Pradhan A, Mishra S, Surolia A, Panda D. Pradhan A, et al. ACS Chem Neurosci. 2021 Jun 2;12(11):1989-2002. doi: 10.1021/acschemneuro.1c00098. Epub 2021 May 19. ACS Chem Neurosci. 2021. PMID: 34008959

4

The Fumarprotocetraric Acid Inhibits Tau Covalently, Avoiding Cytotoxicity of Aggregates in Cells.

González C, Cartagena C, Caballero L, Melo F, Areche C, Cornejo A. González C, et al. Molecules. 2021 Jun 21;26(12):3760. doi: 10.3390/molecules26123760. Molecules. 2021. PMID: 34205516 Free PMC article.

5

The Role of Tau Proteoforms in Health and Disease.

Waheed Z, Choudhary J, Jatala FH, Fatimah, Noor A, Zerr I, Zafar S. Waheed Z, et al. Mol Neurobiol. 2023 Sep;60(9):5155-5166. doi: 10.1007/s12035-023-03387-8. Epub 2023 Jun 2. Mol Neurobiol. 2023. PMID: 37266762 Review.

6

Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers.

Umeda T, Ono K, Sakai A, Yamashita M, Mizuguchi M, Klein WL, Yamada M, Mori H, Tomiyama T. Umeda T, et al. Brain. 2016 May;139(Pt 5):1568-86. doi: 10.1093/brain/aww042. Epub 2016 Mar 28. Brain. 2016. PMID: 27020329

7

Azure C Targets and Modulates Toxic Tau Oligomers.

Lo Cascio F, Kayed R. Lo Cascio F, et al. ACS Chem Neurosci. 2018 Jun 20;9(6):1317-1326. doi: 10.1021/acschemneuro.7b00501. Epub 2018 Mar 1. ACS Chem Neurosci. 2018. PMID: 29378132

8

Neem Derivatives Inhibits Tau Aggregation.

Gorantla NV, Das R, Mulani FA, Thulasiram HV, Chinnathambi S. Gorantla NV, et al. J Alzheimers Dis Rep. 2019 Jun 14;3(1):169-178. doi: 10.3233/ADR-190118. J Alzheimers Dis Rep. 2019. PMID: 31259310 Free PMC article.

9

Intraneuronal Tau Misfolding Induced by Extracellular Amyloid-β Oligomers.

Rudenko LK, Wallrabe H, Periasamy A, Siller KH, Svindrych Z, Seward ME, Best MN, Bloom GS. Rudenko LK, et al. J Alzheimers Dis. 2019;71(4):1125-1138. doi: 10.3233/JAD-190226. J Alzheimers Dis. 2019. PMID: 31524157 Free PMC article.

10

Exploring Membrane Binding Targets of Disordered Human Tau Aggregates on Lipid Rafts Using Multiscale Molecular Dynamics Simulations.

Cheng KH, Graf A, Lewis A, Pham T, Acharya A. Cheng KH, et al. Membranes (Basel). 2022 Nov 4;12(11):1098. doi: 10.3390/membranes12111098. Membranes (Basel). 2022. PMID: 36363654 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year